TCRT — Alaunos Therapeutics Inc · $5.6M cap

Alaunos Therapeutics Inc (TCRT) is a biotechnology company listed on NASDAQ.

Latest reported TCRT revenue for 2026-06-30 was $0. Net income was -$2.0M. TCRT currently screens at market cap $5.6M.

Use this TCRT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TCRT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TCRT SEC filings page. Lician reads the product cache first so this HTML stays unique to Alaunos Therapeutics Inc even when a live quote feed is slow.

Alaunos Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full TCRT income, balance, and cash tables.

  • Revenue$5.0K
  • Net Income-$4.2M
  • Total Assets$2.8M
  • Total Debt$0
  • Free Cash Flow-$3.0M

TCRT recent filings